Schedule 13D ownership disclosure

CUREVAC N V

Common Shares, par value (euro) 0.12 per share · CUSIP: N2451R105

Event date: 2025-12-03

Filing-level shares
0.00
Percent of class
0.00%
  • GSK plcReported CIK 0001131399

    Shares: 0.00 · Class: 0.00%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001999371-25-019650
Form type
SCHEDULE 13D/A
Filer
CureVac N.V.
CIK
CIK 1809122
Filed
Dec 05, 2025
Reporting period
Dec 03, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub